When genetics yielded unsatisfactory answers about pancreatic cancer’s persistent survival, researchers looked beyond the genome – and found telling epigenetic changes

Epithelial-to-mesenchymal transition in pancreatic cancer may play a role in treatment resistance.

Pancreatic cancer is often treated as a homogeneous disease, but new research reveals distinct subtypes of tumor and stromal gene expression

Pancreatic cancer is a challenge to stage because there’s no good molecular imaging method – but three new antibody conjugates may change that

Pancreatic cancer is tough to understand, diagnose and treat. Undeterred researchers are on a quest to crack the case.

The Pathologist’s Top 100 Power List celebrates the exceptional achievments of people in the field.

Learning games are underused, but offer an effective way to engage students and could help them understand and retain knowledge.

But what does the recent approval of this immunotherapy mean for pathology labs?

Tumor-activated DNA minicircles offer a potential solution for cancer detection, treatment, or both.

How research and pathology can prepare you for a life of teaching, learning and innovating